JP2008525453A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008525453A5 JP2008525453A5 JP2007548311A JP2007548311A JP2008525453A5 JP 2008525453 A5 JP2008525453 A5 JP 2008525453A5 JP 2007548311 A JP2007548311 A JP 2007548311A JP 2007548311 A JP2007548311 A JP 2007548311A JP 2008525453 A5 JP2008525453 A5 JP 2008525453A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- mixture
- diazepan
- ylcarbamate
- 500mhz
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63938904P | 2004-12-27 | 2004-12-27 | |
| PCT/US2005/045384 WO2006071548A2 (en) | 2004-12-27 | 2005-12-14 | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008525453A JP2008525453A (ja) | 2008-07-17 |
| JP2008525453A5 true JP2008525453A5 (cg-RX-API-DMAC7.html) | 2009-02-12 |
Family
ID=36615388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548311A Pending JP2008525453A (ja) | 2004-12-27 | 2005-12-14 | 緑内障と、rhoキナーゼを媒介とした他の疾患および症状を治療するためのアミノピラジン・アナログ |
Country Status (16)
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008545660A (ja) * | 2005-05-20 | 2008-12-18 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼ阻害剤として有用なピロロピリジン化合物 |
| MX2008008328A (es) * | 2005-12-22 | 2008-09-15 | Alcon Res Ltd | (indazol-5-il)-pirazinas y (1,3-dihidro-indol-2-ona)-pirazinas para tratar enfermedades y condiciones mediadas con rho cinasa. |
| WO2007126964A2 (en) * | 2006-03-31 | 2007-11-08 | Schering Corporation | Kinase inhibitors |
| BRPI0713187A2 (pt) * | 2006-07-20 | 2012-10-16 | Mehmet Kahraman | método de inibir rho-quinase, método de tratamento de doença mediada por rho-quinase, composto e composição farmacêutica |
| BRPI0717320A2 (pt) | 2006-10-23 | 2013-10-22 | Sgx Pharmaceuticals Inc | Triazóis bicíclicos como moduladores de proteína cinase |
| WO2008070599A1 (en) * | 2006-12-05 | 2008-06-12 | Chung-Ming Sun | Indazole compounds |
| US8648069B2 (en) | 2007-06-08 | 2014-02-11 | Abbvie Inc. | 5-substituted indazoles as kinase inhibitors |
| CN101790526A (zh) * | 2007-06-08 | 2010-07-28 | 雅培制药有限公司 | 用作激酶抑制剂的5-杂芳基取代的吲唑化合物 |
| KR101712576B1 (ko) | 2008-11-10 | 2017-03-06 | 버텍스 파마슈티칼스 인코포레이티드 | Atr 키나제의 억제제로서 유용한 화합물 |
| PL3354650T3 (pl) | 2008-12-19 | 2022-06-13 | Vertex Pharmaceuticals Incorporated | Związki przydatne jako inhibitory kinazy atr |
| AU2010313392B2 (en) * | 2009-10-30 | 2015-07-09 | Janssen Pharmaceutica Nv | Pyrazines as delta opioid receptor modulators |
| BR112012010253A8 (pt) | 2009-10-30 | 2016-10-04 | Janssen Pharmaceutica Nv | compostos de pirimidina como moduladores do receptor delta opioide |
| BR112012010220A2 (pt) * | 2009-10-30 | 2021-02-23 | Janssen Pharmaceutical N.V. | piridinas fenóxi-substituídas como modulares do receptor opioide |
| JP2013526538A (ja) | 2010-05-12 | 2013-06-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | Atrキナーゼ阻害剤として有用な化合物 |
| JP2013526540A (ja) | 2010-05-12 | 2013-06-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | Atrキナーゼ阻害剤として有用な化合物 |
| JP5836367B2 (ja) | 2010-05-12 | 2015-12-24 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | Atrキナーゼ阻害剤として有用な化合物 |
| US9096584B2 (en) | 2010-05-12 | 2015-08-04 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2011143423A2 (en) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| US8962631B2 (en) | 2010-05-12 | 2015-02-24 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| JP2013529643A (ja) | 2010-06-23 | 2013-07-22 | バーテックス ファーマシューティカルズ インコーポレイテッド | Atrキナーゼ阻害剤として有用なピロロピラジン誘導体 |
| CA2832100A1 (en) | 2011-04-05 | 2012-10-11 | Vertex Pharmaceuticals Incorporated | Aminopyrazine compounds useful as inhibitors of tra kinase |
| JP2014522818A (ja) | 2011-06-22 | 2014-09-08 | バーテックス ファーマシューティカルズ インコーポレイテッド | Atrキナーゼ阻害剤として有用な化合物 |
| WO2012178123A1 (en) | 2011-06-22 | 2012-12-27 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| WO2012178125A1 (en) | 2011-06-22 | 2012-12-27 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| AU2012315384B2 (en) | 2011-09-30 | 2017-08-10 | Vertex Pharmaceuticals Incorporated | Treating pancreatic cancer and non-small cell lung cancer with ATR inhibitors |
| IN2014KN00943A (cg-RX-API-DMAC7.html) | 2011-09-30 | 2015-08-21 | Vertex Pharma | |
| US8853217B2 (en) | 2011-09-30 | 2014-10-07 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| US8765751B2 (en) | 2011-09-30 | 2014-07-01 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| RU2018147217A (ru) | 2011-09-30 | 2019-01-18 | Вертекс Фармасьютикалз Инкорпорейтед | Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr |
| EP2776421A1 (en) | 2011-11-09 | 2014-09-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| EP2776429A1 (en) | 2011-11-09 | 2014-09-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| US8841449B2 (en) | 2011-11-09 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| US8841450B2 (en) | 2011-11-09 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2013071090A1 (en) | 2011-11-09 | 2013-05-16 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| CN104582795B (zh) | 2012-04-05 | 2018-04-20 | 沃泰克斯药物股份有限公司 | 可用作atr激酶抑制剂的化合物及其组合疗法 |
| DK2904406T3 (en) | 2012-10-04 | 2018-06-18 | Vertex Pharma | METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE |
| US8912198B2 (en) | 2012-10-16 | 2014-12-16 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| LT3418281T (lt) | 2012-12-07 | 2021-01-11 | Vertex Pharmaceuticals Inc. | Pirazolo[1,5-a]pirimidinai, naudotini kaip atr kinazės inhibitoriai, skirti vėžinių ligų gydymui |
| WO2014143240A1 (en) | 2013-03-15 | 2014-09-18 | Vertex Pharmaceuticals Incorporated | Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase |
| KR101504722B1 (ko) | 2013-06-12 | 2015-03-24 | 한국화학연구원 | 카모로놀 화합물을 유효성분으로 포함하는 심혈관 질환의 예방 및 치료용 약학적 조성물 |
| HUE046727T2 (hu) | 2013-12-06 | 2020-03-30 | Vertex Pharma | Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai |
| ES2777608T3 (es) | 2014-06-05 | 2020-08-05 | Vertex Pharma | Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo |
| US11179394B2 (en) | 2014-06-17 | 2021-11-23 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of Chk1 and ATR inhibitors |
| US11464774B2 (en) | 2015-09-30 | 2022-10-11 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
| GB201715410D0 (en) | 2017-09-22 | 2017-11-08 | Syngenta Participations Ag | Improvements in or relating to organic compounds |
| WO2019119207A1 (en) * | 2017-12-18 | 2019-06-27 | Merck Sharp & Dohme Corp. | Purine inhibitors of human phosphatidylinositol 3-kinase delta |
| CN112142716B (zh) * | 2020-10-29 | 2021-08-31 | 山东新时代药业有限公司 | 一种5元杂芳基取代的吡嗪衍生物及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3719609B2 (ja) * | 1995-12-21 | 2005-11-24 | アルコン ラボラトリーズ,インコーポレイテッド | 緑内障および眼虚血の治療のための特定のイソキノリンスルホニル化合物の使用 |
| US6586425B2 (en) * | 1996-02-21 | 2003-07-01 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
| US5798380A (en) * | 1996-02-21 | 1998-08-25 | Wisconsin Alumni Research Foundation | Cytoskeletal active agents for glaucoma therapy |
| PT956865E (pt) * | 1996-08-12 | 2007-07-30 | Mitsubishi Pharma Corp | Medicamentos compreendendo inibidores da rho cinase. |
| KR100616466B1 (ko) * | 1998-08-17 | 2006-08-29 | 센주 세이야꾸 가부시키가이샤 | 녹내장 예방/치료제 |
| AU4144400A (en) * | 1999-04-27 | 2000-11-10 | Mitsubishi Pharma Corporation | Preventives/remedies for liver diseases |
| US6348494B1 (en) * | 2000-11-21 | 2002-02-19 | American Home Products Corporation | Ethers of o-desmethyl venlafaxine |
| ES2266171T3 (es) * | 2000-03-16 | 2007-03-01 | Mitsubishi Pharma Corporation | Compuestos de amida y su uso. |
| JP4776138B2 (ja) * | 2000-03-31 | 2011-09-21 | 田辺三菱製薬株式会社 | 腎臓疾患予防・治療剤 |
| EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | RHO KINASE INHIBITORS |
| DE60234269D1 (de) | 2001-11-21 | 2009-12-17 | Pharmacia & Upjohn Co Llc | Substituierte aryl 1,4-pyrazin derivate |
| AU2002358390A1 (en) * | 2001-12-18 | 2003-06-30 | Astrazeneca Ab | Novel compounds |
| US7094789B2 (en) * | 2002-07-22 | 2006-08-22 | Asahi Kasei Pharma Corporation | 5-substituted isoquinoline derivatives |
| CA2496197A1 (en) * | 2002-08-20 | 2004-03-04 | Neurogen Corporation | 5-substituted-2-arylpyrazines as modulators of crf receptors |
| GB0219746D0 (en) * | 2002-08-23 | 2002-10-02 | Inst Of Ex Botany Ascr | Azapurine derivatives |
| WO2004084824A2 (en) * | 2003-03-24 | 2004-10-07 | Merck & Co., Inc. | Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| GB2400101A (en) * | 2003-03-28 | 2004-10-06 | Biofocus Discovery Ltd | Compounds capable of binding to the active site of protein kinases |
| CA2543644A1 (en) * | 2003-10-27 | 2005-05-06 | Astellas Pharma Inc. | Pyrazine derivatives and pharmaceutical use thereof |
| WO2005058876A1 (en) * | 2003-12-16 | 2005-06-30 | Gpc Biotech Ag | Pyrazine derivatives as effective compounds against infectious diseases |
| EP1737841A1 (en) * | 2004-04-01 | 2007-01-03 | Astellas Pharma Inc. | Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
-
2005
- 2005-12-14 EP EP05854156A patent/EP1830853B1/en not_active Expired - Lifetime
- 2005-12-14 AT AT05854156T patent/ATE519488T1/de not_active IP Right Cessation
- 2005-12-14 ZA ZA200704959A patent/ZA200704959B/xx unknown
- 2005-12-14 CN CN200580046786XA patent/CN101102773B/zh not_active Expired - Fee Related
- 2005-12-14 PL PL383491A patent/PL383491A1/pl not_active Application Discontinuation
- 2005-12-14 BR BRPI0519508-0A patent/BRPI0519508A2/pt not_active IP Right Cessation
- 2005-12-14 CA CA2590261A patent/CA2590261C/en not_active Expired - Fee Related
- 2005-12-14 MX MX2007007797A patent/MX2007007797A/es active IP Right Grant
- 2005-12-14 AU AU2005322338A patent/AU2005322338B2/en not_active Ceased
- 2005-12-14 US US11/302,825 patent/US20080269249A2/en not_active Abandoned
- 2005-12-14 WO PCT/US2005/045384 patent/WO2006071548A2/en not_active Ceased
- 2005-12-14 KR KR1020077017035A patent/KR100994173B1/ko not_active Expired - Fee Related
- 2005-12-14 ES ES05854156T patent/ES2368338T3/es not_active Expired - Lifetime
- 2005-12-14 JP JP2007548311A patent/JP2008525453A/ja active Pending
- 2005-12-23 TW TW094146211A patent/TW200633709A/zh unknown
- 2005-12-26 AR ARP050105535A patent/AR053110A1/es not_active Application Discontinuation
-
2010
- 2010-05-05 US US12/774,399 patent/US20100216777A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2428503T3 (es) | 1,4-Diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos | |
| EP4549440A1 (en) | Class of prmt5 inhibitors and use thereof | |
| JP3346437B2 (ja) | 複素環化合物 | |
| JP4859672B2 (ja) | 5−ht4受容体作動活性を有する1−イソプロピル−2−オキソ−1,2−ジヒドロピリジン−3−カルボキサミド誘導体 | |
| ES2975436T3 (es) | Enantiómeros (R) y (S) de n-(5-(3-hidroxipirrolidin-1-il)-2-morfolinooxazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4- il)oxazol-carboxamida como inhibidores de IRAK4 para el tratamiento del cáncer | |
| ES2385118T3 (es) | Derivados de quinazolina sustituida con sulfoximina como inmunomoduladores, su preparación y uso como medicamentos | |
| JP2012519196A5 (cg-RX-API-DMAC7.html) | ||
| CN103724329B (zh) | 4-[5-(吡啶-4-基)-1h-[1,2,4]三唑-3-基]吡啶-2-甲腈的制备方法 | |
| TW200536545A (en) | Pyrazine derivatives and pharmaceutical use thereof | |
| ATE419252T1 (de) | Antagonisten des a2b-adenosinrezeptors | |
| EA035168B1 (ru) | Полициклические соединения в качестве ингибиторов тирозинкиназы брутона | |
| JP6204223B2 (ja) | チオピラノース化合物等の製造方法 | |
| CN103724258B (zh) | 一种索拉非尼的制备方法 | |
| CN119768400A (zh) | 一种稠环化合物、其用途及含其的药物组合物 | |
| CN102321073A (zh) | 一种尼罗替尼的制备方法 | |
| IE55839B1 (en) | Azetidine compounds | |
| WO1996004251A1 (en) | Heterocyclic compound | |
| CN103497146B (zh) | 2-(n-芳甲基哌啶-4-氨基)-4-(取代苯酚)苯环衍生物及其制备方法与应用 | |
| CN114026069B (zh) | 制造(s)-3-羟基-1-(1h-吲哚-5-基)-2-氧代-吡咯烷-3-甲酸3,5-二氟-苄基酰胺的工艺 | |
| CN120302970A (zh) | 制备抗体药物缀合物的方法 | |
| CN102924548A (zh) | 卡培他滨的合成方法 | |
| CN103087132B (zh) | β-核苷的合成 | |
| CHEN et al. | Synthesis and Anti-tumor Evaluation of Nitrile-Containing Gambogic Acid Derivatives | |
| CN104910068A (zh) | 一种2-氰基异烟酸酰肼1.5对甲苯磺酸盐的合成方法 | |
| CN102516146B (zh) | 5位为氮的四元氮杂螺环衍生物及其制备方法和用途 |